Vancouver, British Columbia–(Newsfile Corp. – February 5, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) is pleased to announce that it has appointed Hongming Luo as a director of the Company. Mr. Luo brings extensive experience in the technology sector, namely focusing on AI, Blockchain and Healthcare Tech, as well as the derivatives markets. Mr. Luo replaces Harveer Sidhu, who has resigned as a director, effective February 4, 2025. The Company would like to thank Mr. Sidhu for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
“Daniel Liu” Chief Executive Officer
Email: daniel@republictechs.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239697
Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…
Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…
Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…
IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…
PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…
NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Rokt, the leading ecommerce technology company using machine learning…